Fairchem Organics Ltd Q1 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/luuqtlao36sgisicdypec1kx.pdf

Key Takeaways


Topline & Margin Recovery

Jariwala: "This margin, we feel will be sustainable, because of 2 reasons. One is the economy of scale, which will be kicking in and second thing is because of the forward integration of the 2 product streams. So overall, we feel fairly confident that these margins will be sustainable in long run."

Capacity & Volume Trajectory


Forward Integration & New Products

Jariwala: "We haven't created any new Greenfield facility for that. So, that is one thing. And second thing is forward integration would keep us ahead of our, I mean, future any competition, if currently there is no competition, but in future also, if any competition comes, we are way ahead of anyone else."

Competitive Position & Moat

Jhaveri: "That is the reason no one else is in this business."

Customer Concentration & Mix Shift


Biodiesel & Undisclosed Projects


Guidance & Commitments

CommitmentSpecificsTimeline
Capacity utilization rampIncrease utilization by 10–15% every year toward full capacityNext 3 years
Tocopherol plant start50% tocopherol plant to begin operations; full production within one month of trial runsDecember 2022
Value-added product contributionNew products to contribute to top line and bottom lineQ3 or Q4 FY23
Nutraceutical shareDouble from current ~3–4% of businessNo fixed date; intent stated
Biodiesel operationsProject to go into operationsEnd of calendar year 2022
Margin sustainability18%+ EBITDA margin sustainable; will try to increase above 18%Long run
Top-line growth ambitionStrive to achieve 20%+ growth; continuously improve top and bottom line annuallyOngoing

Key Metrics

MetricQ1 FY23
Operational revenue₹225 crore, up ~62% YoY
EBITDA₹40 crore, up ~22% YoY
EBITDA margin17.77%
Net profit after tax₹27 crore, up ~21% YoY
PAT margin12%
Volume processed14,000–15,000 metric tons, flat QoQ; Q1 FY22 was ~13,000 metric tons
Capacity utilization64% on 90,000-ton capacity (120,000-ton capacity in place only from end of June 2022)
Annual volume growth target10% to 15%, driven by paint and ink industry growth
Peak capacity utilization assumption~92% of installed capacity considered fair
Prime products share of revenue77% in value terms (Linoleic acid, Dimer acid, nutraceutical)
Dimer acid share of FY22 revenue~30% to 35%
Nutraceutical share of business~3% to 4%, intend to double
Input-to-output yield ratio~94% to 96%
Raw material cost advantageRs. 60–70 per liter vs edible oil at Rs. 100 per liter
Top customer revenue contribution40% in FY21 and FY22, expected to reduce in FY23